Browse the conference topics below and explore the research areas
covered during Pharma 2027.
This session explores emerging technologies in drug delivery, including nanoparticle-based systems, liposomal formulations, and controlled-release mechanisms. Discussions will focus on improving bioavailability, reducing side effects, and enhancing patient compliance through innovative delivery platforms.
A deep dive into the role of nanotechnology in modern pharmaceutics, covering nanoparticle design, drug encapsulation, and targeted delivery to specific tissues or cells. Speakers will discuss current applications and the regulatory considerations surrounding nanomedicine.
This session examines advances across multiple delivery routes, comparing the benefits and formulation challenges of oral, transdermal, and site-specific targeted delivery systems, with a focus on patient-centric design.
Covering the development lifecycle of biologics and biosimilars, this session addresses formulation stability, manufacturing complexity, and the regulatory pathways required to bring biologic therapies to market.
An exploration of the unique manufacturing, storage, and delivery challenges associated with cell and gene therapies, including scalability, cold-chain logistics, and quality control in personalized medicine.
This session highlights recent progress in mRNA-based therapeutics and vaccine platforms, discussing formulation stability, delivery mechanisms, and lessons learned from large-scale vaccine development and deployment.
A comprehensive look at regulatory requirements across major markets, this session helps attendees understand how to navigate differing compliance standards and streamline global drug approval strategies.
This session focuses on maintaining quality throughout the drug development and manufacturing process, covering Good Manufacturing Practice (GMP) standards, quality assurance systems, and risk-based quality management approaches.
Speakers will break down the drug approval processes of major regulatory bodies, including the EMA and FDA, offering practical guidance on submission strategies and common regulatory hurdles.
This session addresses the technical and operational challenges of scaling pharmaceutical production, from lab-scale to commercial manufacturing, with emphasis on process efficiency and cost management.
An examination of how pharmaceutical companies collaborate with Contract Development and Manufacturing Organizations (CDMOs) and Contract Manufacturing Organizations (CMOs), covering partnership models, risk management, and outsourcing best practices.
This session discusses strategies for building resilient pharmaceutical supply chains, addressing disruptions, raw material sourcing, and risk mitigation in an increasingly complex global market.
A forward-looking session on how AI and machine learning are transforming drug discovery, from target identification to predictive modeling, and accelerating development timelines.
This session explores how digital tools, real-world data, and decentralized trial models are reshaping clinical research and improving efficiency in R&D processes.
Covering the full journey from clinical trial design to market entry, this session discusses strategic planning for R&D investments and approaches to achieving successful global market access.
Ready to contribute to Pharmaceutics 2027?
Submit your research abstract or download the conference brochure for complete details.
